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Abstract
Background: The identification of proteins by mass spectrometry is a standard method in biopharmaceutical quality control
and biochemical research. Prior to identification by mass spectrometry, proteins are usually pre-separated by
electrophoresis. However, current protein staining and de-staining protocols are tedious and time consuming, and
therefore prolong the sample preparation time for mass spectrometry.
Methodology and Principal Findings: We developed a 1-minute covalent pre-gel staining protocol for proteins, which does
not require de-staining before the mass spectrometry analysis. We investigated the electrophoretic properties of derivatized
proteins and peptides and studied their behavior in mass spectrometry. Further, we elucidated the preferred reaction of
proteins with Uniblue A and demonstrate the integration of the peptide derivatization into typical informatics tools.
Conclusions and Significance: The Uniblue A staining method drastically speeds up the sample preparation for the mass
spectrometry based identification of proteins. The application of this chemo-proteomic strategy will be advantageous for
routine quality control of proteins and for time-critical tasks in protein analysis.
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Introduction
Proofing the identity of compounds during the manufacturing
chain is a basic obligation in the pharmaceutical industries.
Adequate quality control procedures are therefore mandatory and
strictly supervised by regulatory bodies [1]. Additionally, fake
drugs threaten the health of patients [2–4]. This makes additional
quality controls necessary for products, which are already in
circulation or imported. But also in biological research and
development, the confirmation of the identity of molecules is
crucial. This is especially true for laboratories working with
proteins, since those are usually purified from complex mixtures
and difficult to distinguish by their biochemical properties only.
Nowadays, proteins in most of the cases are identified based on
mass spectrometry (MS) data, since current MS methods offer high
sensitivity, speed and accuracy and hence permit reliable conclu-
sions on the nature of a protein in reasonable time. Moreover, MS
methods are applicable to virtually any protein and are not limited
to the N-terminal sequence such as Edman sequencing.
Usually proteins need to be pre-separated, before they can be
subjected to MS analysis. This is efficiently done by gel
electrophoresis, which has the additional advantage to remove
low molecular weight contaminants such as salts. For extremely
complex samples, such as entire cell disintegrates with several
thousand proteins, a two-dimensional gel electrophoresis (2D-GE)
is necessary, which separates the proteins first by their isoelectric
point and subsequently by their molecular weight [5]. However,
2D-GE is time and labor intense.
For analyzing partially purified or pure proteins, a one-
dimensional gel electrophoresis (1D-GE) [6] is sufficient and
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on a single gel. Considering the much higher possible through-put
compared to two-dimensional gel electrophoresis, we focus in our
study on one-dimensional gel electrophoreses.
Independently, if 1D-GE or 2D-GE is chosen, the proteins need
to be stained or labeled in order to be visible. In some cases, a
selective stain might be applicable [7]. But for most cases, a
general protein dye needs to be applied. The most sensitive protein
stain, which is visible at natural light, is the silver staining.
However, it is cumbersome and troubling in mass spectrometry
analyses [8]. Therefore, the less sensitive Coomassie stain became
the current de facto standard for protein staining [9]. Several
protocols for Coomassie staining are given in the literature, which
are either optimized for sensitivity, speed or mass spectrometry
compatibility [10,11]. Out of those, the staining with colloidal
Coomassie is currently the method of choice, if the samples are
intended for later analysis by mass spectrometry. However,
considering the quickest protocols, three hours are necessary for
colloidal Coomassie staining [11], and another four hours for
preparing selected gel pieces for MS [12–15]. A significant part of
this time is consumed by de-staining steps.
In comparison, the 1D-GE and the MS analysis take only about
one to two hours each.
Besides the time issue, many tedious manual steps are necessary
for the processing of Coomassie stained gel pieces, which increases
the risk of sample contamination, for example by human keratin.
Automation of the sample processing is possible, but its costs are
considerable and the reliability and flexibility of robots is
sometimes not satisfactory.
Altogether, we identified a vast potential for optimization in the
sample preparation for mass spectrometry; especially in the
protein staining/de-staining procedures. We sought after a protein
staining method, which reduces the sample preparation effort
before mass spectrometry to a minimum and consequently permits
faster protein identification results. The requirements for such a
staining method would be: Rapidity, visibility of stained proteins at
natural light, compatibility with gel electrophoresis, compatibility
with mass spectrometry and current data processing work-flows as
well as simple adoption to existing laboratory procedures.
In the following study we demonstrate how those conditions can
be met by covalent pre-gel staining of the proteins with Uniblue A.
Results
Covalent staining procedure and electrophoretic
properties of derivatized proteins
After some theoretical considerations and initial testing of
several reactive protein dyes, Uniblue A seemed to be the most
promising candidate, due to its solubility in water, commercial
availability with adequate purity and low price. Additionally, its
blue color aids in achieving a sufficient optical contrast. Uniblue A
exhibits broad and intense absorption in the visible range with a
maximum at 593.5 nm (Supplemental Fig. S1, lmax=596 nm
according to Sigma Aldrich). This is practically the same
absorption maximum as for Coomassie with a lmax of 595 nm
[16]. Therefore the same settings for the scanning of gels can be
used for obtaining the best contrast. Since we suspected a reaction
with amines (Fig. 1) at basic pH, we performed the staining
reaction in an amine-free NaHCO3 buffer at a pH of 8–9. We
discovered that staining can be obtained at different temperatures,
ranging from 37uC up to 100uC. But whereas the reaction requires
about 1 hour at 60uC, sufficient covalent pre-gel staining of the
protein with Uniblue A can be obtained within only one minute at
100uC (Fig. 2A). Prolonged incubation at this temperature results
in thermal protein degradation.
Further steps of the protocol include quenching of excess
Uniblue A, reduction and alkylation. Altogether, the sample
preparation for the SDS-PAGE can be completed in less than ten
minutes. Additionally to the blue protein bands, also the reaction
products with Tris buffer are visible and serve as running front
indicator. Those low-molecular compounds disappear rapidly
during the fixing of the gel.
For recombinant cystatin we determined a quantitative sensitivity
of about 1 mg protein. This is less sensitive than current Coomassie
staining protocols. However, the Uniblue A derivatization is fully
compatible with subsequent Coomassie staining. Therefore, the
intensity of protein bands gels can be increased by double-staining,
if required (Fig. 2B, C and S3). Clearly, several of the advantages of
the Uniblue A protocol would be lost after sequential staining, in
particular the saving of analysis time. However, even assuming
insufficient staining by Uniblue A for some samples, only a few
minutes are required for the sample preparation, which is very little
in comparison to several hours, which generally can be saved. As an
analytical strategy, several lanes of the same sample, with and
without prior Uniblue A derivatization, can be run in the same gel.
In this approach, one lane with Uniblue A derivatized proteins
could be used as internal standard forthe progress of electrophoresis
and for rapid identification by MS, whereas the other lanes of
derivatized or un-derivatized protein could be subsequently stained,
in order to evaluate purity.
The apparent molecular weights of pre-stained and un-labeled
Coomassie stained proteins are in agreement (see Fig. 2B, C and
S2). Hence, the electrophoretic mobility of the proteins is not
changed significantly by their covalent staining, which is in
congruence with previous studies employing dabsyl chloride [17]
or Remazol dyes [18]. Presumably, these small appendices do not
contribute to the binding of SDS.
Figure 1. Covalent staining of proteins by nucleophilic
addition of Uniblue A. The vinyl sulfone group (red) reacts with
primary amines, preferably on lysine residues. The sulfate group (green)
supports the solubility of the dye and affects the ionization properties
of the labeled peptide during mass spectrometry measurements.
doi:10.1371/journal.pone.0031438.g001
Mass Spectrometry Compatible Staining of Proteins
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31438On the other side, the negatively charged Uniblue A does
strongly influences the isoelectric point of the derivatized proteins.
Modified proteins are shifted towards the basic region of a 2D gel.
Even prolonged isoelectric focusing does not result in defined spots
(Fig. S4). The 2D analysis also reveals that increased derivatization
leads to more diffuse spots, although the apparent molecular
weight is not affected significantly.
Sensitivity and resolution are reduced for pre-stained proteins,
but protein patterns of pre-stained and un-labeled Coomassie
stained proteins are comparable, as demonstrated for the
Escherichia coli disintegrate (Fig. 2C).
For SDS-PAGE gels intended for subsequent mass spectromet-
ric analyses, the staining intensity and the resolution are perfectly
adequate.
Shortened work-up for mass spectrometry and peptide
tracking
De-staining is not required for the work-up of gel pieces. Also
reduction and alkylation can be skipped, since those steps are
already integrated into the SDS-PAGE sample preparation. In
comparison to the current best-in-class methods, the staining time
could be reduced from three hours to less than ten minutes, and the
sample work-up time from four hours to about two hours. In total,
the required sample processing time was condensed to less than a
third, and the manual handling steps could be significantly reduced,
which reduces the risk of contamination. No stain particles are
present, which reduces the chance of blockages which occasionally
occur in the NanoLC analysis of Coomassie stained samples.
Tagged proteins and peptides display color in the visible
spectrum and their fate can be tracked visually. This allows for the
direct monitoring of sample processing steps, such as extraction
and re-dissolution of peptides. This feature facilitates optimization
and validation of sample preparation methods.
The additional sulfate group increases the solubility of
derivatized proteins and peptides, which supports their extraction,
especially in cases of very hydrophobic species.
Elucidation of amino acid serving as reaction partner for
Uniblue A
Uniblue A contains a single vinyl sulfone group that may react
with primary amines via nucleophilic addition (Fig. 1). Covalently
modified residues will have a defined monoisotopic mass shift of
484.0399 Da.
However, alsootherpotential reactionpartners suchas sulfhydryl
groups or hydroxyl groups might be possible. The actual reaction
needed to be evaluated by mass spectrometry data. Therefore the
data setswererun allowing forpotentialUniblue A modificationson
lysine, cysteine, asparagine, glutamine, threonine, arginine, and
tyrosine. Surprisingly, it turned out, that under the given conditions
only lysine residues were derivatized, but neither other amine
containing residues such as asparagine and glutamine nor
alternative functional groups. Therefore it can be suggested that
the e-amino group of lysine is the preferred reaction partner for a
nucleophilic addition of Uniblue A. Moreover, only a fraction of the
lysines was derivatized. Based on assigned peptide spectra, up to 17
Uniblue A modifications were found for BSA, a lysine rich protein
(Tab. 1). Surprisingly, only few or no Uniblue A modifications were
found for other samples, although the protein was successfully
stained, as evaluated visually from the SDS-PAGE gels. This
indicates that the sensitivity is reduced for Uniblue A derivatized
peptides. But it also has to be kept in mind, that this quantification
method for judging the ratio of modified peptides, the so-called
‘‘spectral counting’’, is limited and might show huge variations,
especially when it comes to low abundance peptides [19]. On the
other side, when detected, Uniblue A modified peptides exhibit a
different, chemically assisted, fragmentation behavior, which
supports their evaluation with high significance, as discussed below.
These data are crucial for the design of efficient database
searches, since only one potential modification site, namely
+484.0399 Da at lysine, has to be considered.
The successful staining of cysteine-free recombinant cystatin
adds biochemical proof that the staining does not depend on the
presence of cysteine (Fig. S2, S3, S4).
Figure2.Electrophoretic properties ofUniblueA stained proteins.A) SDS-PAGE gel showing pre-stainedmolecular weight marker andUniblue
A (Uni A) derivatized Rituximab antibody chains. The staining was achieved within 1 minute. The third lane contains the equal concentration of un-
derivatized Rituximab sample (nat). B) The same gel after subsequent staining with Coomassie, now also revealing the un-derivatized Rituximab sample.
Staining intensity andprotein profilesarecomparable. C) E. coli TOP10, transformedwith pMAL-c4x andauto-induced. Uniblue A (UniA) derivatized and
un-derivatized (nat) disintegration sample display comparable protein profiles after Coomassie staining. The assumed recombinant protein band was
cut and subjected to nanoLC-MS/MS analysis, confirming the identity with .80% MS/MS based sequence coverage in both samples.
doi:10.1371/journal.pone.0031438.g002
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integration of modification into standard bioinformatic
work-flows
Raw MS/MS data were converted into mzXML and evaluated
automatically (see Materials and Methods). In short, the search was
performed against a concatenated target-decoy database [20] using
the Open Mass Spectrometry Search Algorithm [21] (OMSSA).
The peptide hits were validated by PeptideProphet [22] and
ProteinProphet [23]. After this automatic processing, the raw data
and identification results could be easily converted into valid
PRoteomics IDEntifications database [24] (PRIDE) XML, using
the PRIDE converter tool [25], and uploaded to the repository.
Covalent derivatization with Uniblue A has been added by the
PRIDE team as a protein modification (PSI-MOD) for the ontology
lookup service (OLS) with the comma separated value (CSV) term
MOD: 01659. Figure 3 shows the entry of an identifiedpeptide with
Uniblue A modification as deposited in the PRIDE database. This
peptide was assigned with high significance, expressed by an
X!Tandem E-value of 0.0056 and a PeptideProphet probability
score of 0.9979.
Trypsin requires a basic arginine or lysine side chain for
substrate recognition [26]. Even small chemical modifications that
remove the charge, such as methylation or acetic anhydride
acetylation result in inhibition of the trypsin activity [27,28].
Consequently, at positions with Uniblue A derivatized lysines no
proteolytic cleavage could be found.
During mass spectrometric analysis, tagged and un-tagged
peptides exhibited slightly different behavior. In general, the
Uniblue A modification has a tendency to reduce the charge state
of the molecules in positive ionization mode due to its negative
sulfate group. Figure 4 compares the fragmentation spectrum of a
doubly charged Uniblue A derivatized peptide with the fragmen-
tation spectrum of a triply charged untagged peptide of the same
sequence. Both spectra were found in the same sample (BSA_dry,
PRIDE accession #11793, scans 820 and 1547). In this example,
the N-terminal lysine of the tryptic peptide is derivatized. The
mass shift allows the clear assignment of the N-terminal fragment
ions a1-NH3 and b1, which otherwise would be outside the mass
range. Whereas the position of the C-terminal y-ions was not
affected, all N-terminal a/b-series ions were shifted, which
facilitates the assignment of the peaks b10 to b14. Additionally,
Figure 3. Annotation of a Uniblue A derivatization in the PRIDE repository. The peptide TWEEIPALDKELK was modified at position 10
(MOD:01659) and belongs to the identified recombinant protein MALELZ|MALELZ_LACZA|MALE-lacZ of experiment # 13516.
doi:10.1371/journal.pone.0031438.g003
Table 1. NanoLC-MS/MS identification results for gel bands of proteins.
Bovine serum albumin Rituximab, heavy chain Rituximab, light chain lacZ-a ´ from E.coli
Uni A Uni A+ Coom Uni A Uni A+ Coom Uni A Uni A+ Coom Uni A Coom
Coom Coom Coom
MS/MS spectra 2898 2851 2778 2905 2818 2852 2887 2818 2869 2980 2838
ProteinProphet
Probability
11 11 1 11 1 111
MS/MS Sequence
coverage
32.5% 52.1% 40.2% 27.7% 26.0% 41.6% 33.8% 58.1% 62.9% 82.3% 83.8%
Total ident.
peptides
43 90 93 19 14 102 20 55 125 111 120
Uniblue A deriv. 0 17 N.A. 0 0 N.A. 0 0 N.A. 6 N.A.
PRIDE accession # 12567 12565 12564 12571 12569 12568 12575 12573 12572 13516 13515
Proteins were either covalently labeled with Uniblue A (Uni A) before electrophoresis or stained with Coomassie (Coom) after electrophoresis. Also sequential staining
with both methods was applied (Uni A+Coom). The bands of interest were cut, tryptically digested and subjected to nanoLC-MS/MS identification (see Methods).
doi:10.1371/journal.pone.0031438.t001
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improved. Altogether more fragment ions can be assigned
automatically for the Uniblue A derivatized peptide.
This finding was further investigated by comparing MS/MS
spectra of native and Uniblue A derivatized peptides in the same
sample, to exclude other influences such as different concentrations
or run-to-run variability. Three MS/MS spectra pairs are provided
as Supplemental Spectra S1. Especially for short peptides the
derivatized peptide spectra provide more evaluable and assignable
signals. The E-value of individual peptide identifications was
typically improved by at least one order of magnitude for the
derivatized version of the peptide compared to the native one.
Comparison of protein identification results after Uniblue
A staining and Coomassie staining
To examine the overall performance of this rapid covalent
derivatization protocol in comparison to the standard Coomassie
based strategy, we compared the identification results after
PeptideProphet/ProteinProphet validation (Tab. 1). Both methods
yield identification results which comply with strict acceptance
criteria. All proteins wereidentified with a ProteinProphet probability
of 1.0000. At least 6 unique peptides were proven and the MS/MS
based sequence coverage was at least 26% in all procedures.
This is remarkable, since analytically challenging proteins have
been employed for this study. Bovine serum albumin undergoes
post-translational proteolytical processing and contains 17 disulfide
bonds. Further, three phosphorylation sites and a copper binding
site are probable [29]. Its high lysine content might support the
staining, but increase at the same time the data complexity due to
partial cleavage events. The Rituximab mouse-human chimeric
antibody on the other side, consists of 262 subunits, which are
connected by disulfide bonds [30]. Additionally, glycosylations
might be present. The successful identification of those real-life
samples underlines the practical usability of our method.
Figure 4. MS/MS fragmentation of an Uniblue A derivatized peptide. The direct comparison of MS/MS fragmentation spectra of Uniblue A
derivatized (top) versus un-labeled (bottom) peptide KVPQVSTPTLVEVSR displays significantly increased signal intensities for the derivatized N-
terminal ions (a- and b- series, shown in red). The defined mass shift of 484.0399 m/z for modified residues allows the detection of fragments, which
otherwise would be outside the measuring range (fragments a1-NH3 and b1).
doi:10.1371/journal.pone.0031438.g004
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Uniblue A is probably caused by matrix suppression effects during
the mass spectrometry, since the samples are washed for less time
compared to the Coomassie protocol. This was confirmed by the
analysis of samples which were first derivatized with Uniblue A
and after electrophoresis stained with Coomassie. For two of the
three samples, the double staining led to a dramatically increased
number of validated peptides, whereas in only one case the
number remained about the same. This demonstrates that
Uniblue A derivatization is in principle compatible with mass
spectrometry based protein identification. Optimized protocols
that address sample-to-sample variation and matrix suppression
might further improve possible sequence coverage results.
Application of Uniblue A derivatization method to
complex samples
To prove the suitability of the method for complex samples, we
applied the covalent derivatization to disintegrates of Escherichia coli
cells producing a recombinant protein. Uniblue A derivatized and
Coomassie stained samples exhibit the sample protein profile (see
Fig.2C), underliningthesuitability of the method e.g.for expression
clone screening. The supposed recombinant protein at approximately
50 kDa (theoretical molecular weight from sequence: 50,871 Da) was
cut and subjected to NanoLC-MS/MS, yielding an excellent MS/
MS based sequence coverage above 80% in both cases. Since for
some parts of the sequence the data are complementary, the
combined MS/MS sequence coverage reaches 92.0% (Fig. S5).
Further, the overall detection of proteins in the putative MalE-lacZa
bands was compared, to investigate the sensitivity for low abundance
proteins (Fig. 5). Applying a ProteinProphet threshold of 0.9, 12
proteins were identified with both staining strategies. Another 13
proteins were found only in the Uniblue A pre-stained band,
compared to 8 proteins, which only were detected in the Coomassie
stained band. Altogether it can be concluded that both staining
strategies exhibit comparable sensitivity for low abundance proteins,
and that the staining methods complement each other.
Discussion
In our study we present a protocol for the rapid staining of
proteins and their subsequent analysis by SDS-PAGE and mass
spectrometry. The method is applicable for pure proteins as well as
for complex mixtures. The SDS-PAGE based protein profiles of
derivatized samples are comparable with those of un-derivatized
samples in one-dimensional gel electrophoresis, indicating that the
electrophoretic mobility in SDS-PAGE is not significantly affected.
This was already demonstrated for other covalent protein dyes,
namely dabsyl chloride [17] or Remazol dyes [18]. Uniblue A
derivatization is not compatible with two-dimensional gel
electrophoresis, since the isoelectric properties of the proteins are
compromised. The resolution of Uniblue A derivatized proteins is
slightly reduced for the 1D-GE, and the staining is less intense
compared to standard Commassie staining protocols. However,
for the localization of abundant proteins in a 1D-GE gel for
subsequent mass spectrometry analysis, those restrictions are not
critical. The rapidity of the protocol allows for the ‘‘at-line’’
analysis of proteins. This can be applied for example in the
monitoring of the enzymatic cleavage of recombinant fusion
proteins.
The required time for sample work-up prior to mass
spectrometric analyses can be reduced drastically. Additionally,
the visibility of the modified proteins and peptides enables their
direct tracking and facilitates the optimization and validation of
protocols.
By allowing for different potential derivatization sites in the
database search, we could prove that the nucleophilic addition
with Uniblue A reaction was highly selective for lysine residues.
Integrating the defined mass shift +484.0399 Da at lysine into
proteomics software tools enabled automated data evaluation of
data sets generated after Uniblue A derivatization. The EBI
RESID database for protein modifications does not contain any
modification, which would result in a monoisotopic weight
correction of 480 to 490 Da [http://www.ebi.ac.uk/RESID/;
RESID-CWeightp#480:490]. Therefore the false annotation of a
Uniblue A modification is impossible.
Previous studies have demonstrated that sulfonation at the N-
term of peptides supports the generation of fragmentation spectra
with improved y-series and therefore facilitates peptide identifica-
tion and de-novo sequencing by MALDI-PSD-MS and ESI-MS
[31,32]. The same phenomenon can be observed after derivati-
zation of peptides with Uniblue A, which also contains a sulfone
side group, although the derivatization could take place at various
positions of a peptide, depending on the location of the lysine.
Consequently, Uniblue A tagging is beneficial for automatic or
manual peptide identification.
The inhibition of tryptic cleavage at derivatized lysines can be
employed to generate longer tryptic peptide fragments. Some
peptides, such as YENGKYDIK and KFEKDTGIK in PRIDE
Experiment #13516 (MalE-lacZa) only were identified as Uniblue
A derivatized peptide. Covalent lysine derivatization by using
propionic anhydride, resulting in the neutralization of the charge
and thus blocking trypsin cleavages, is employed in the study of
histone modifications [33]. Combining tryptic digestion MS/MS
data sets of Coomassie stained and Uniblue A derivatized samples
improved the total MS/MS based sequence coverage of a
recombinant protein. Further, different proteins of lower abun-
dance could be detected. Both findings indicate that those two
different staining methods are complementary.
The ‘‘peptidic diversity’’ of tryptic digestions of Uniblue A
derivatized proteins is increased by partial derivatization,
inhibition of derivatized lysine cleavage sites, different chromato-
graphic properties between un-derivatized and labeled peptides,
defined mass shifts during mass spectrometry and different
ionization behavior. In theory, this reduces on one side the
sensitivity for the mass spectrometric analysis, but on the other side
Figure 5. Comparison of identified proteins in the putative E.
coli MalE-lacZa band. Different proteins were identified from the
Uniblue A and the Coomassie stained band of the over-expressed
protein. Applying a ProteinProphet score of 0.9 as threshold, 12
proteins were found with both staining methods. 13 proteins were
exclusively detected with the Uniblue A staining method, 8 proteins
only with the Coomassie staining.
doi:10.1371/journal.pone.0031438.g005
Mass Spectrometry Compatible Staining of Proteins
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31438supports improved LC-MS based sequence coverages. The
sensitivity of current mass spectrometry instrumentation is already
extraordinary high and should not represent a bottleneck. From a
practical point of view, we did not experience technical problems
in the detection and identification of peptides. The employed
algorithms deal well with the potential modifications and the
identifications were executed by the automated scripts in about
20 minutes using standard computers.
Further, the enhanced solubility of derivatized proteins and
peptides might be used for the analysis and recovery of highly
hydrophobic proteins.
Our proposed method is primarily thought to provide a novel
and rapid interface between gel electrophoresis and mass
spectrometry. This should be especially interesting for the
pharmaceutical quality control, but also for speeding up the
protein analysis in research and development. Further, the
covalent staining has a number of implications concerning the
biophysical properties of derivatized proteins and peptides, which
can be exploited for defined analytical questions.
Additionally, we invite to think about novel strategies in the
development of really mass spectrometry compatible stains and
provide a suitable chemical strategy.
Materials and Methods
Cultivation of Escherichia coli TOP10/pMAL-c4x and
production of recombinant protein
E. coli TOP10/pMAL-c4x (transformed by electroporation) was
grown on Overnight Express
TM Instant TB Medium (Novagen
Inc.). 50 mL of sterile Overnight Express medium containing
50 mg/ml carbenicillin were given into a 100 mL Erlenmeyer flask
and inoculated with 100 mL of a 50% glycerol stock solution of
recombinant E. coli TOP10/pMAL-c4x (stored at 280uC). The
cells were grown for 16 hours at 37uC and 250 rpm. The
production of the gene product of the vector, a MalE-lacZa fusion
protein was auto-induced after consumption of glucose and the
following growth on lactose. The cultivation broth was harvested
by centrifugation at 4uC. The pellets were stored at 220uC.
Disintegration of E. coli and TCA/acetone precipitation of
intracellular proteins
The E. coli pellet was re-suspended in 1 mL of 100 mM
carbonate buffer (derivatization buffer solution), transferred into a
1.5 mL Eppendorf tube and sonicated for 5 min. The suspension
was clarified by centrifugation at 4uC. Subsequently, 0.1 mL of
ice-cooled TCA/acetone solution (1 g/mL TCA in acetone) was
added to 0.9 mL of supernatant. This mixture was kept at 4uC for
2 h and centrifuged for 10 min in a pre-cooled micro-centrifuge.
The supernatant was discarded and the pellet was washed three
times with 1 mL of 90% acetone. Excess of acetone was eliminated
by drying and the pellet was re-suspended in 100 mL of 100 mM
carbonate buffer (derivatization buffer solution).
Buffer exchange by ultrafiltration: Preparation of
Rituximab antibodies
Commercial MabTheraH Rituximab (Hoffmann- La Roche,
S.A.) was pre-treated by ultrafiltration. 250 mL of Rituximab
(500 mg/50 ml) and 250 mL of 100 mM carbonate buffer
(derivatization buffer solution) were placed into a 0.5 ml 3,000
MWCO AmiconH Ultra centrifugal filter unit (Millipore
TM). After
30 min centrifugation at 14,0006g, the permeate was discharged
and new carbonate buffer was added to the retentate. This
procedure was repeated at least five times. Finally, the Rituximab
retentate was resuspended in 125 mL of 100 mM carbonate buffer.
The final concentration of Rituximab was 20 mg/mL.
Production and purification of recombinant amaranth
cystatin
Recombinant amaranth cystatin (see Supplemental Sequence
S1) was produced and purified as previously described [34].
Briefly, E. coli M15 (pREP 4) cells transformed with the pQE-2
vector, containing the amaranth cystatin coding sequence, were
grown under agitation at 37uC in Super Broth medium,
containing 100 mgmL-1 of carbenicillin and 25 mgmL
21 of
kanamycin, until they reached an OD600 of 0.5. Cystatin
expression was induced by the addition of 0.1 mM IPTG and
the cells were harvested after 5 h by centrifugation. The amaranth
cystatin was purified from cell lysates using an affinity nickel resin
column that was previously equilibrated with 50 mM NaH2PO4
buffer containing 300 mM NaCl and 10 mM imidazole (pH 8.0).
The cystatin was eluted by 250 mM imidazole, dissolved in the
same buffer. The purified cystatin was exhaustively dialyzed
against water in a microdialysis system (BRL Life technologies,
Inc.) with a molecular weight cut-off of 1,000 Da and concen-
trated in a Savant speedVac vacuum. The protein concentration
of the purified cystatin was determined by the BioRad microassay,
using serum albumin as standard. Theoretical properties of the
recombinant cystatin were calculated using ProtParam [35].
Uniblue A stain for visualization of proteins
10 mL of 200 mM Uniblue A (Sigma-Aldrich, #298409)
solution in derivatization buffer, consisting of 100 mM NaHCO3
and 10% SDS, pH 8–9, were added to 90 mL protein solution.
Following the sample were heated at 100uC for one minute to
perform the staining. Subsequently 100 mL of reducing solution
composed of 10% glycerol and 20 mM dithiotreitol (DTT) in
200 mM Tris buffer with pH 6.8, were added in order to reduce
cysteins and to adjust the pH for the electrophoresis. Excess
Uniblue A reacts with Tris, resulting in a blue compound, which
serves as running front indicator in electrophoresis. The sample
was heated another minute at 100uC in order to achieve efficient
reduction and allowed to cool to room temperature. Subsequently,
20 mL alkylation solution containing 550 mM iodoacetamide
(IAA) was added. After 5 minutes incubation time the samples
were subjected to SDS-PAGE.
Dry protein samples or samples in compatible buffers (i.e. free of
amines) can be diluted directly with the derivatization buffer
solution to a protein concentration of 5 mg/mL. In other cases, a
prior trichloroacetic acid (TCA)/acetone precipitation or buffer
exchange by ultrafiltration is recommended (see below).
As positive control, bovine serum albumin (BSA) in derivatiza-
tion buffer was used at a concentration of 10 mg/mL.
1D-GE, SDS-PAGE
SDS-PAGE was carried out according to the methods of
Laemmli [6] and Sambrook [36]. Different concentrations of
cystatin and the Uniblue A stained cystatin (10–0.1 mg) were
analyzed in SDS–PAGE 12.5%. The protein in the gel was fixed
in 40% (v/v) ethanol and 10% (v/v) acetic acid for 20 min and
stained with PhastGel Blue R-350 (Amersham, BioScience)
following the supplier’s instructions. The Uniblue A stained
cystatin was detected directly in the gel.
Two-dimensional (2D) gel electrophoresis
Two-dimensional gel electrophoresis was performed according
to the method of Bjellqvist et al. [37]. Dry IPG strips (7 cm long,
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isoelectric focusing buffer (7 M urea, 2 M thiourea, 20 mM DTT,
4% CHAPS, 0.5% ampholite 3–10, 0.001% bromophenol blue),
containing 1 mg of protein sample. IEF was conducted with an
Ettan IPGphor II system (Amersham Biosciences). Focusing was
carried out in four steps: 250 V for 1 h, 500 V 0.5 h followed by
1000 V 0.5 h, and finally 8000 V for 2.5 h. After focusing, the gels
were equilibrated twice for 15 min in equilibration solution. The
first equilibration was performed in a solution containing 6 M
urea, 30% w/v glycerol, 2% w/v SDS, 0.001% bromophenol
blue, 50 mM Tris-HCl buffer, pH 8.8 and 1% w/v DTT. The
second equilibration solution was modified by the replacement of
DTT by 2.5% w/v iodoacetamide. For the second dimension, the
proteins were separated on 12.5% SDS polyacrylamide gels.
Protein spots were visualized using PhastGel Blue R-350
(Amersham Biosciences).
In-gel digestion for protein bands
For in-gel digestion of protein bands, the protocols of
Shevchenko [14,38] have been adopted with few modifications.
In-gel reduction/alkylation is not required since this step is already
included in the SDS-PAGE sample preparation.
After the SDS-PAGE, the Uniblue A stained bands could be cut
directly from the gel and chopped into cubes with about 1 mm of
edge length. The cubes were transferred to vials and covered by
acetonitrile. Typically the cubes became whitish and shrunk after
about 5 minutes. If not, the acetonitrile solution was exchanged
one or two times. The shrunk gel pieces were dried in a vacuum
centrifuge. The dry gel pieces were re-hydrated in 10 ng/mL
trypsin solution (Promega V511A in 10 mM ammonium bicar-
bonate) and incubated for 30 min at 60uC. Previous studies had
shown that the reductive methylation of Promega trypsin shifts its
catalytic optimum to 50–60uC. Therefore, similar peptide yields
can be obtained after 30 min digestion at elevated temperatures,
compared to overnight digestions at 37uC [39]. After tryptic
digestion, the peptides could be extracted by addition of an
acetonitrile: 5% trifluoroacetic acid mixture (2:1) and incubation
for 15 min at 60uC.
The extraction solution was collected into a new tube and dried
in a vacuum centrifuge. Prior to LC-MS/MS analysis, the peptides
were dissolved in 20 mL of 0.1% (v/v) formic acid.
Gels were washed and fixed, if they were going to be scanned or
stored. First, the gel was shaken for 5 min in a solution containing
40% methanol and 10% acetic acid, following for 20 min in a
solution containing 10% methanol and 7.5% acetic acid. Finally,
the gel was washed with the first solution for at least 3 h, until the
excess of colorant was eliminated.
NanoLC-MS/MS measurements
NanoLC-MS/MS analyses were performed on an Agilent 1100
HPLC sytem with nanoLC-ChipCube, coupled with an Agilent
LC/MSD Trap XCT Ultra. For instrument control the vendor’s
programs ChemStation Rev.B.01.03 and TrapControl version 6.1
were used. Solvent A for chromatography was 0.1% formic acid,
solvent B 99% acetonitrile in 0.1% formic acid. 8 mL of sample
were loaded with a flow of 4 mL/min solvent A on the 40 nL
enrichment column of a Agilent G4240-62001 chip column. The
flow rate for the analytical chromatography was 0.3 mL/min. After
5 min washing with 3% solvent B, the flow path was changed to
the analytical column (43 mm675 mm, Zorbax 300SB-C18,
5 mm). During the following 27 min the solvent B concentration
was increased to 45%. Following the column was cleaned by a 3-
minute gradient to 95% solvent B and re-equilibrated 6.5 min
with initial conditions. The total time for the chromatography
method was 42.5 min. The electron spray ionization was enabled
by a capillary voltage of 1,900 V and a nitrogen gas flow of 4 L/
min at 325uC. Parent spectra were measured in positive mode,
standard-enhanced with an integrated ion current (ICC) smart
target setting of 200,000 and a maximal accumulation time of
100 ms. The scan range was from 200 to 1400 m/z. Collision
induced dissociation (CID) fragmentation was performed auto-
matically with preference for multiply charged precursor ions. The
fragmentation energy was adjusted online by smart parameter
setting.
Evaluation of nanoLC-MS/MS data
In order to enable a target-decoy search strategy [20] with
estimation of false positive rates (FDR), a decoy database with
reverse sequences was generated and merged with the original
one. The forward database was constructed by using the entries of
the SwissProt database, supplemented by the sequences of the
Rituximab chains, as reported in DrugBank [40] (accession
number DB00073), and the theoretical amino acid sequence of
the pMAL-c4x vector gene product, MalE-lacZa (sequence
derived from technical information of New England BioLabs).
The final search data base consisted of approx. 1,000,000 entries.
Agilent XCT ultra *.yep data files were converted to *.mzXML
files using the CompassXport 3.0.x program, provided by Bruker.
Following the mzXML files were automatically processed by a
DOS BATCH script OMSSAVALIDATION.BAT (see below), em-
ploying OMSSA 2.1.x [21] as database search engine and
PeptideProphet [22] and ProteinProphet [23], versions of Trans-
Proteomic Pipeline v4.x [41] for hit validation.
To account for the additional potential protein modification on
lysine with Uniblue A, an additional entry was defined in the
usermods.xml file in the OMSSA directory:
,MSModSpec.
,MSModSpec_mod.
,MSMod value=‘‘usermod3’’.121,/MSMod.
,/MSModSpec_mod.
,MSModSpec_type.
,MSModType value=‘‘modaa’’.0,/MSModType.
,/MSModSpec_type.
,MSModSpec_name.Uniblue A on K,/MSModSpec_-
name.
,MSModSpec_monomass.484.039891,/MSModSpec_mo-
nomass.
,MSModSpec_averagemass.484.5016,/MSModSpec_aver-
agemass.
,MSModSpec_n15mass.0,/MSModSpec_n15mass.
,MSModSpec_residues.
,MSModSpec_residues_E.K,/MSModSpec_residues_E.
,/MSModSpec_residues.
,/MSModSpec.
The modification 121 now is known by OMSSA as ‘‘Uniblue A
on K’’ and identified by a mass shift of 484.039891 Da
monoisotopic mass, or 484.5016 Da average mass, respectively.
For OMSSA searches, two missed cleavages were allowed,
‘‘carbamidomethyl on cysteine’’ was defined as fixed modification
and ‘‘deamidation on glutamine/asparagine’’ and ‘‘Uniblue A on
lysine’’ as variable modifications. ‘‘Oxidation on methionine’’
could be omitted, since no methionine oxidation was found in
exploratory data base searches. This finding can be attributed to
the rapid sample work-up. To allow for subsequent validation of
hits by PeptideProphet/ProteinProphet, the e-value was set to
1E6. Precursor and fragment mass tolerances were left at the
OMSSA default values, i.e. 2.0 Da for the precursor and 0.8 Da
for the fragment masses.
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minimal peptide length of 5 amino acid residues was specified
and a non-parametric validation model based on decoy results.
Raw data and identification results were converted into
standard-compliant PRIDE XML using the PRIDE converter,
v2.x [25], applying a ProteinProphet probability cut-off of 0.9 and
a cut-off for peptides of 0.05. This PRIDE XML files were
submitted to the PRIDE server (http://www.ebi.ac.uk/pride/),
where the data can be found in the project ‘‘Rapid pre-gel
visualization of proteins with mass spectrometry compatibility’’.
Covalent derivatization with Uniblue A has been added by the
PRIDE team as a protein modification (PSI-MOD) for the
ontology lookup service (OLS) with the comma separated value
(CSV) term MOD: 01659.
Manual calculations of fragmentation spectra were conducted
with mmass 3.7 [42].
DOS BATCH script for automated processing of mzXML
files
For automated database search and hit validation a DOS BATCH
script called OMSSAVALIDATION.BAT has been written. Provided, that
the necessary software is installed, the following code can be pasted
into a *.bat file and executed on all *.mzXML files of a directory.
@ECHO OFF
ECHO *** Converting mzXML files to mgf ***
FOR %%I IN (*.mzXML) DO MzXML2Search -mgf -ACID -
M2-2 -P5 -I0.01 -B10 -T5000.0%%I
ECHO *** OMSSA search: Decoy database, trypsin, pep.xml
output ***
REM decoy entries in database customdb start with decoy_;
reverse decoy database generated with FastaTools 0.9 and merged
with original database using mergeFasta.pl
FOR %%I IN (*.mgf) DO omssacl -d c:\blastdb\customdb -fm
%%I -v 2 -mf 3 -mv 4,121 -he 1e6 -w -op %%I_OMSSA_TPP.-
pep.xml
ECHO *** Fix linking of MS/MS spectra ***
sed -i ‘‘s/\.mgf_OMSSA_TPP\.pep\.xml//ig’’ *OMS-
SA_TPP.pep.xml
ECHO *** Validation of OMSSA results with PeptideProphet/
ProteinProphet; NOOCAM NOGROUPS ***
FOR %%I IN (*OMSSA_TPP.pep.xml) DO interactparser
ppval_%%I %%I -L5 -Etrypsin -C -P
FOR %%I IN (ppval*.pep.xml) DO peptideprophetparser %%I
DECOY=decoy MINPROB=0 NONPARAM
FOR %%I IN (ppval*.pep.xml) DO refreshparser %%I
c:\blastdb\customdb
FOR %%I IN (ppval*.pep.xml) DO proteinprophet %%I
%%I.prot.xml NOOCCAM NOGROUPS
DEL ppval_ppval*
DEL sed*
ECHO *** Standard OMSSA Search ***
FOR %%I IN (*.mgf) DO omssacl -d c:\blastdb\customdb -fm
%%I -v 2 -mf 3 -mv 4,121 -w -ob %%I_OMSSA_DECOY.oms
UV/VIS spectrum of Uniblue A
Anaqueoussolutionof0.01 mg/mLUniblueAwasmeasured ina
range from 300 to 800 nm against water as blank on a BECKMAN
DU 640 spectrometer. The resulting data were converted into ASCII
and visualized using a LaTeX typesetting system.
Venn diagram
The R package VennDiagram [43] was employed for drawing
the Venn diagram with R 2.14.0. Proteins of the PRIDE
experiments #13515 and #13516 from the analysis of the
putative MalE-lacZa fusion protein were included, with a
ProteinProphet score of .0.9 as treshold.
Patent Application
For the pre-gel staining strategy with Uniblue A a patent was
filed with the number MX/a/2009/013417.
Mass spectrometry data availability
Mass spectrometry raw data and identification results have been de-
posited at the EBI PRIDE server (http://www.ebi.ac.uk/pride/). The
data will be made public after acceptance of the manuscript. For
review, the data can be accessed with Username: review00783 and
Password: JT-FskaG. PRIDE accession codes for individual samples
are given in Table 1 or within the manuscript. Peptides modified with
Uniblue A are annotated in the individual protein hit view as follows:
MOD: 01659 from database MOD at position XX. Monoisotopic
D: 484.039893, Uniblue A derivatized residue. An example is given in
Figure 3.
Supporting Information
Sequence S1 Recombinant amaranth cystatin fasta
sequence.
(DOC)
Figure S1 UV/VIS spectrum of Uniblue A (0.01 mg/mL
in water). Uniblue A exhibits strong absorption in the visible
wavelength region with a maximum lmax at 593.5 nm and a
shoulder at about 630 nm.
(DOC)
Figure S2 Comparison of electrophoretic mobility of
Uniblue A derivatized recombinant cystatin with the
electrophoretic mobility of un-derivatized cystatin (Coo-
massie staining). There is no significant change of the
electrophoretic mobility of cystatin detectable.
(DOC)
Figure S3 Evaluation of the sensitivity of Uniblue A pre-
staining using recombinant cystatin. Gel A shows the gel
directly after running and fixation, gel B after additional staining
with PhastGel Blue R. Uniblue A derivatized cystatin bands can
be detected visually down to about 1 mg of loaded protein.
Subsequent staining with PhastGel Blue R allows the detection of
about 0.1 mg of loaded protein.
(DOC)
Figure S4 Two-dimensional gel electrophoresis of Uni-
blue A derivatized recombinant cystatin. Uniblue A
derivatized recombinant cystatin cannot be focused, even after
18930Vh of isoelectric-focusing. An increasing derivatization
degree leads to a shift of the isoelectric point of the protein
towards the basic region. Further, the band gets more diffuse,
although the apparent molecular weight does not change
significantly.
(DOC)
Figure S5 MS/MS based sequence coverage for MalE-
lacZa fusion protein from E. coli expression vector
pMAL-c4x.
(DOC)
Spectra S1 Supplemental MS/MS spectra of native and
Uniblue A derivatized peptides.
(DOC)
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